Get started
Award

Clinical Affiliate of the Type 1 Diabetes Trialnet

Description: PUBLIC HEALTH RELEVANCE: Type 1 diabetes (T1D) occurs in genetically predisposed individuals as a result of the progressive, destruction of pancreatic �-cells, which are the insuli-producing cells. The disease process results in loss of insulin secretion and life-long insulin-dependence, and unfortunately, most often occurs in children, adolescents, and young adults. It is possible to interfere with this destructive process that leads to T1D, and as part of TrialNet, we are taking investigative steps to move us closer to the ultimate goal of prevention of T1D.
Funding type: cooperative_agreement
Funder scheme: U01
Start date: 2009-09-30
End date: 2020-04-30
Investigator: DAVID BAIDAL
Institution: UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
Subfield: Genetics
Funded outputs count: 177
Funder award ID: U01DK085499
OpenAlex ID: G1980346786
β-Cell Dysfunction Identifies Individuals With Single Autoantibody Positivity at Increased Risk of Type 1 Diabetes Progression
2026 · Emily K. Sims, Lu You, et al. · Diabetes Care
Quantification of Proinsulin in Human Plasma by Proteolysis-Aided Peptide Immunoaffinity-Liquid Chromatography-Tandem Mass Spectrometry
2026 · Sara K Shijo, Elisha Goonatilleke, et al. · Clinical Chemistry
Islet Autoantibody Patterns Vary by Race and Ethnicity and Area Deprivation Index for Individuals at Risk for Type 1 Diabetes
2026 · Ananta Addala, Susanne Cabrera, et al. · Diabetes Care
PDF
Extended Follow-up of Type 1 Diabetes Immunotherapy Trial Participants Suggests Benign Side Effect Profile
2026 · Laura M. Jacobsen, Dave Cuthbertson, et al. · Diabetes Care
Type 2 Diabetes Genetic Risk and Type 1 Diabetes Heterogeneity and Progression
2025 · Taylor M. Triolo, Jay M. Sosenko, et al. · Diabetes · 3
Genetic Predictors of Response to Oral Insulin for Type 1 Diabetes Prevention
2025 · Lu You, Hemang M. Parikh, et al. · Diabetes Care
PDF
Circulating senescence-associated secretory phenotype factors across the stages of type 1 diabetes in a cross-sectional cohort
2025 · Camille Préfontaine, Jasmine Pipella, et al. · Scientific Reports · 6
PDF
Baseline Insulin Secretion Determines Response to Abatacept in Stage 1 Type 1 Diabetes
2025 · Alfonso Galderisi, Alice L.J. Carr, et al. · Diabetes · 4
Stage 1 type 1 diabetes memory B lymphocytes transcriptionally differ from healthy controls and harbor insulin-binding specificities
2025 · Lindsay E Bass, Wyatt J McDonnell, et al. · ImmunoHorizons · 2
Neutrophil-enriched gene signature correlates with teplizumab therapy resistance in different stages of type 1 diabetes
2025 · Gabriele Sassi, Pierre Lemaitre, et al. · Journal of Clinical Investigation · 4
PDF
Novel Approach for Assessing Outcomes of Type 1 Diabetes Prevention Trials Over a Fixed Time Interval
2025 · Emily K. Sims, William E. Russell, et al. · Diabetes · 3
Contrasting Adult and Pediatric Populations in a Cohort of At-Risk Relatives in The T1D TrialNet Pathway to Prevention Study
2025 · Erin L. Templeman, Lauric A. Ferrat, et al. · Diabetes Care · 25
Development and recalibration of a multivariable type 1 diabetes prediction model for type 1 diabetes across multiple screening studies
2025 · Erin L. Templeman, Lauric A. Ferrat, et al. · BMC Medicine · 7
PDF
Genetic Risk and Transition Through Preclinical Stages of Type 1 Diabetes
2025 · Andrea K Steck, Hemang M Parikh, et al. · The Journal of Clinical Endocrinology & Metabolism · 5
Evaluation of proinsulin(F25D) as a targeting ligand for insulin-binding B cells in autoimmune diabetes
2025 · Kyle D. Apley, Lindsay E. Bass, et al. · Drug Delivery and Translational Research · 4
M120 Risk Score Improves Identification of Children at High Risk of Developing Clinical Type 1 Diabetes and Reports Short-term Response to Preventive Immunotherapy
2025 · Minh V. Le,, Leonard C. Harrison, et al. · Diabetes Care · 4
PDF
The Disposition Index in Autoantibody-Positive Individuals at Risk for Type 1 Diabetes
2025 · Heba M. Ismail, David Cuthbertson, et al. · Diabetes · 6
PDF
Activated polyreactive B cells are clonally expanded in autoantibody positive and patients with recent-onset type 1 diabetes
2025 · Catherine A. Nicholas, Fatima A. Tensun, et al. · Cell Reports · 12
Comparative Analysis of the Sensitivity, Specificity, Concordance, and 5-Year Predictive Power of Diabetes-Related Autoantibody Assays
2025 · Jeffrey P. Krischer, Sarah Muller, et al. · Diabetes · 14
PDF
IA-2A positivity increases risk of progression within and across established stages of type 1 diabetes
2025 · Emily K. Sims, David Cuthbertson, et al. · Diabetologia · 26
Metabolic Phenotype of Stage 1 and Stage 2 Type 1 Diabetes Using Modeling of β Cell Function
2025 · Alfonso Galderisi, Jacopo Bonet, et al. · The Journal of Clinical Endocrinology & Metabolism · 9
A Glucose Fraction Independent of Insulin Secretion: Implications for Type 1 Diabetes Progression in Autoantibody-Positive Cohorts
2025 · Jay M. Sosenko, David Cuthbertson, et al. · Diabetes Technology & Therapeutics · 2
PDF
Enhancing Type 1 Diabetes Immunological Risk Prediction with Continuous Glucose Monitoring and Genetic Profiling
2024 · Eslam Montaser, Leon S. Farhy, et al. · Diabetes Technology & Therapeutics · 36
Characteristics of autoantibody-positive individuals without high-risk HLA-DR4-DQ8 or HLA-DR3-DQ2 haplotypes
2024 · Maria J. Redondo, David Cuthbertson, et al. · Diabetologia · 10
PDF
Trajectory of beta cell function and insulin clearance in stage 2 type 1 diabetes: natural history and response to teplizumab
2024 · Alfonso Galderisi, Emily K. Sims, et al. · Diabetologia · 17
PDF
Year
Topic